Hypoallergenic fragment of Par j 2 increases functional expression of Toll-like receptors in atopic children

Authors: Pace, E.1; Duro, G.1; Grutta, S. La1; Ferraro, M.1; Bruno, A.1; Bousquet, J.2; Bonsignore, G.1; Gjomarkaj, M.1

Source: Allergy, Volume 61, Number 12, December 2006 , pp. 1459-1466(8)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Background: 

Parietaria judaica (Par j) is one of the main causes of allergy in the Mediterranean countries. The activation of Toll-like receptor 4 (TLR4) by lipopolysaccharide (LPS) inhibits nasal inflammation of atopic children. Objective: 

To examine, in vivo and in vitro, the effect of recombinant Par j 2 (rPar j 2) and of its fragments (1-55 and 52-102) on atopic children. Methods: 

We used skin prick test for in vivo evaluations. We assessed, in vitro, in peripheral blood mononuclear cells (PBMC), the effect of rPar j 2 and of the two fragments on neutrophil chemotaxis, on CD45RO, on TLR2 and TLR4 expression, on LPS binding and on interferon (IFN)-γ release, by a microchemotaxis chamber, by flow cytometry and by enzyme-linked immunosorbent assay, respectively. Results: 

In vivo while rPar j 2 induced a positive skin reaction, 1-55 and 52-102 fragments did not. In vitro, while rPar j 2 increased both CD45RO expression and neutrophils chemotaxis in PBMC, both Par j 2 fragments did not. 1-55 fragment of Par j 2 upregulated both TLR2 and TLR4 expression and LPS binding, while the rPar j 2 and 52-102 fragment did not. Finally, 1-55 fragment of Par j 2 induced IFNγ release, while the rPar j 2 and 52-102 fragment did not. Conclusions: 

Hypoallergenic 1-55 fragment, upregulating innate immunity receptors and increasing IFNγ, might re-orientate, in atopics, the immune system toward a physiologic balance between Th1 and Th2 responses.

Keywords: allergy; innate immunity; Th1 and Th2 responses

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1398-9995.2006.01234.x

Affiliations: 1: Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Palermo, Italy 2: Institut National de la Santè et de la Recherche Medical U-454, Montpellier, France

Publication date: 2006-12-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page